Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Barton

Showing results (531-540 of 671) with videos related to

Pageof 68
Sort By:
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1992
The molecular genetics of Candida albicansT J Lott, P T Magee, R Barton, et al.
Muscle & Nerve|July 20, 2019
Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlinElisabeth R Barton, Jennifer Pham, Becky K Brisson, et al.
Plos One|August 30, 2008
Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in ratSatsuki Fukushima, Steven R Coppen, Joon Lee, et al.
The Journal of Prevention of Alzheimer'S Disease|January 15, 2023
ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aß Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development PlanE Siemers, J Hitchcock, K Sundell, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 19, 2010
Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppressionBingjing Wang, Zhaohui Yang, Becky K Brisson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancerG Los, K Benbatoul, D P Gately, et al.
Trials|August 14, 2014
Feasibility of a randomized controlled trial of functional strength training for people between six months and five years after stroke: FeSTivaLS trialKathryn Mares, Jane Cross, Allan Clark, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 9, 2015
Differences in Longer-Term Smoking Abstinence After Treatment by Specialist or Nonspecialist Advisors: Secondary Analysis of Data From a Relapse Prevention TrialFujian Song, Vivienne Maskrey, Annie Blyth, et al.
The Journal of Clinical Investigation|October 2, 2012
HEXIM1 controls satellite cell expansion after injury to regulate skeletal muscle regenerationPeng Hong, Kang Chen, Bihui Huang, et al.
Neurology|January 2, 2024
Emerging Subspecialties: Pediatric Movement Disorders NeurologySimran Kahlon, Christopher R Barton, Amal Abu Libdeh, et al.
Pageof 68

Showing results (531-540 of 671) with videos related to

Sort By:
Pageof 68
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1992
The molecular genetics of Candida albicansT J Lott, P T Magee, R Barton, et al.
Muscle & Nerve|July 20, 2019
Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlinElisabeth R Barton, Jennifer Pham, Becky K Brisson, et al.
Plos One|August 30, 2008
Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in ratSatsuki Fukushima, Steven R Coppen, Joon Lee, et al.
The Journal of Prevention of Alzheimer'S Disease|January 15, 2023
ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aß Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development PlanE Siemers, J Hitchcock, K Sundell, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 19, 2010
Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppressionBingjing Wang, Zhaohui Yang, Becky K Brisson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Quantitation of the change in GADD153 messenger RNA level as a molecular marker of tumor response in head and neck cancerG Los, K Benbatoul, D P Gately, et al.
Trials|August 14, 2014
Feasibility of a randomized controlled trial of functional strength training for people between six months and five years after stroke: FeSTivaLS trialKathryn Mares, Jane Cross, Allan Clark, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|July 9, 2015
Differences in Longer-Term Smoking Abstinence After Treatment by Specialist or Nonspecialist Advisors: Secondary Analysis of Data From a Relapse Prevention TrialFujian Song, Vivienne Maskrey, Annie Blyth, et al.
The Journal of Clinical Investigation|October 2, 2012
HEXIM1 controls satellite cell expansion after injury to regulate skeletal muscle regenerationPeng Hong, Kang Chen, Bihui Huang, et al.
Neurology|January 2, 2024
Emerging Subspecialties: Pediatric Movement Disorders NeurologySimran Kahlon, Christopher R Barton, Amal Abu Libdeh, et al.
Pageof 68